Study Name: Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
13 locations found
- GSK Investigational Site
Location: Lebanon, New Hampshire 03756
- GSK Investigational Site
Location: Washington, District of Columbia 20007
- GSK Investigational Site
Location: Durham, North Carolina 27710
- GSK Investigational Site
Location: Greenville, South Carolina 29605
- GSK Investigational Site
Location: Atlanta, Georgia 30341
- GSK Investigational Site
Location: Fort Myers, Florida 33916
- GSK Investigational Site
Location: Nashville, Tennessee 37203
- GSK Investigational Site
Location: Memphis, Tennessee 38120
- GSK Investigational Site
Location: Cleveland, Ohio 44106
- GSK Investigational Site
Location: Detroit, Michigan 48202
- GSK Investigational Site
Location: Scottsdale, Arizona 85259
- GSK Investigational Site
Location: Tucson, Arizona 85724
- GSK Investigational Site
Location: Salt Lake City, Utah 84112
|